Stage IB Breast Cancer

specific

Stage IB includes: (T1, N0, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T1, N0, M0, G1, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T1, N0, M0, G2, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T1, N0, M0, G2, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T1, N0, M0, G2, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T1, N0, M0, G3, HER2 Status: Positive, ER Status: Negative, PR Status:

79

Centers

115

Active Trials

Cancer Funding

Top Centers for Stage IB Breast Cancer(79)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
172.8
2
NCI Comprehensive
Active Research Program
61.2
3
NCI Comprehensive
Active Research Program
61.2
4
NCI Comprehensive
Active Research Program
61.2
5
NCI Comprehensive
Active Research Program
61.2
6
NCI Comprehensive
Active Research Program
61.2
7
NCI Comprehensive
Active Research Program
61.2
8
NCI Comprehensive
Active Research Program
61.2
9
NCI Comprehensive
Active Research Program
61.2
10
NCI Comprehensive
Active Research Program
61.2
11
NCI Comprehensive
Active Research Program
61.2
12
NCI Comprehensive
Active Research Program
61.2
13
NCI Clinical
Active Research Program
61.2
14
NCI Comprehensive
Active Research Program
61.2
15
NCI Comprehensive
Active Research Program
61.2
16
NCI Comprehensive
Active Research Program
61.2
17
NCI Clinical
Active Research Program
61.2
18
NCI Comprehensive
Active Research Program
61.2
19
Active Research Program
61.2
20
Active Research Program
61.2
21
NCI Comprehensive
Active Research Program
61.2
22
NCI Comprehensive
Active Research Program
61.2
23
NCI Clinical
Active Research Program
61.2
24
NCI Comprehensive
Active Research Program
61.2
25
NCI Comprehensive
Active Research Program
61.2
26
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
61.2
27
Active Research Program
61.2
28
NCI Clinical
Active Research Program
61.2
29
Active Research Program
61.2
30
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
61.2
31
Active Research Program
61.2
32
NCI Comprehensive
Active Research Program
61.2
3361.2
34
Active Research Program
61.2
35
Active Research Program
61.2
36
Active Research Program
61.2
37
Active Research Program
61.2
38
Active Research Program
61.2
39
Active Research Program
61.2
40
Active Research Program
61.2
41
Active Research Program
61.2
42
NCI Comprehensive
Active Research Program
40.7
43
NCI Comprehensive
Active Research Program
40.7
44
NCI Comprehensive
Active Research Program
40.7
45
NCI Comprehensive
Active Research Program
40.7
46
NCI Comprehensive
Active Research Program
40.7
47
NCI Comprehensive
Active Research Program
40.7
48
NCI Comprehensive
Active Research Program
40.7
49
NCI Comprehensive
Active Research Program
40.7
50
NCI Comprehensive
Active Research Program
40.7
51
NCI Comprehensive
Active Research Program
40.7
52
NCI Comprehensive
Active Research Program
40.7
53
NCI Comprehensive
Active Research Program
40.7
54
NCI Comprehensive
Active Research Program
40.7
55
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
40.7
56
NCI Comprehensive
Active Research Program
40.7
57
NCI Comprehensive
Active Research Program
40.7
58
NCI Comprehensive
Active Research Program
40.7
59
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
40.7
60
NCI Comprehensive
Active Research Program
40.7
61
NCI Comprehensive
Active Research Program
40.7
62
NCI Comprehensive
Active Research Program
40.7
63
NCI Comprehensive
Active Research Program
40.7
64
Active Research Program
40.7
65
NCI Basic_laboratory
Active Research Program
40.7
66
Active Research Program
40.7
67
Active Research Program
40.7
68
Active Research Program
40.7
6940.7
70
Active Research Program
40.7
71
Active Research Program
40.7
72
Active Research Program
40.7
73
Active Research Program
40.7
74
NCI Comprehensive
29.8
7529.8
7629.8
7729.8
7829.8
79
BC CancerVancouver, BC
29.8

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →